Bosulif and Sucralfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bosulif (bosutinib) and Sucralfate (sucralfate). Common drug interactions include nausea among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Bosulif and Sucralfate. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Bosulif?

Bosulif has active ingredients of bosutinib. eHealthMe is studying from 9,401 Bosulif users. Check the latest studies of Bosulif.

What is Sucralfate?

Sucralfate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 17,548 Sucralfate users. Check the latest studies of Sucralfate.



On Jul, 17, 2026

23 people who take Bosulif and Sucralfate together, and have interactions are studied.

Bosulif and Sucralfate drug interactions.

What are the common drug interactions of Bosulif and Sucralfate, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Dyspnoea (difficult or laboured respiration)
  3. Fatigue (feeling of tiredness)
  4. Vomiting
  5. Abdominal pain
  6. Asthma
  7. Chest discomfort
  8. Chest pain
  9. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  10. Confusional state

male:

  1. Diarrhoea
  2. Abdominal discomfort
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Asthenia (weakness)
  5. Dry skin
  6. Fluid retention (an abnormal accumulation of fluid in the blood)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  9. Pain
  10. Renal pain (kidney pain)

What are the common drug interactions of Bosulif and Sucralfate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Diarrhoea
  2. Hepatic enzyme increased
  3. Vomiting

20-29:

n/a

30-39:

  1. Arthralgia (joint pain)
  2. Bone pain
  3. Diarrhoea
  4. Myalgia (muscle pain)
  5. Vomiting

40-49:

  1. Depressed mood
  2. Fatigue (feeling of tiredness)
  3. Libido decreased (loss of interest in sex)
  4. Myalgia (muscle pain)
  5. Rash

50-59:

  1. Abdominal pain
  2. Asthma
  3. Chest discomfort
  4. Chest pain
  5. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  6. Confusional state
  7. Depression
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Dyspnoea (difficult or laboured respiration)
  10. Fatigue (feeling of tiredness)

60+:

  1. Abdominal discomfort
  2. Diarrhoea
  3. Oropharyngeal pain
  4. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  5. Tremor (trembling or shaking movements in one or more parts of your body)
  6. Iron deficiency
  7. Petechiae (a small red or purple spot caused by bleeding into the skin)
  8. Pruritus (severe itching of the skin)
  9. Upper respiratory tract infection
  10. Asthenia (weakness)

What are the existing conditions these people have? *

  1. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 17 people, 73.91%
  2. Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 2 people, 8.70%
  3. Nausea (feeling of having an urge to vomit): 2 people, 8.70%
  4. Lipids Abnormal: 2 people, 8.70%
  5. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 8.70%
  6. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 8.70%
  7. Depression: 2 people, 8.70%
  8. Bone Marrow Transplant Rejection: 2 people, 8.70%
  9. Blood Pressure Abnormal: 2 people, 8.70%
  10. Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Bosulif and Sucralfate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bosulif and Sucralfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bosulif:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sucralfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bosulif and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sucralfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bosutinib and sucralfate (the active ingredients of Bosulif and Sucralfate, respectively), and Bosulif and Sucralfate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: